Regeneron

$305M Power Play: Anne Wojcicki Outbids Regeneron for 23andMe

Anne Wojcicki has outbid Regeneron with a $305 million offer to reclaim 23andMe, the genetic health tech company she co-founded.

23andMe Finds $256M Buyer in Regeneron After Chapter 11 Filing

Regeneron is acquiring 23andMe’s core assets for $256 million following the genetic testing company’s Chapter 11 filing.